Clonidine Transdermal System, USP 0.3 mg/day, 4 Patches (NDC 51862-455-01) per Carton (51862-455-04), Rx only, Manufactured for: Mayne Pharma Greenville, NC 27834
Published June 29, 2022 · Recall initiated: June 9, 2022
Summary
FDA records drug Class II recall D-1152-2022, published June 29, 2022 and initiated June 9, 2022. Recalling firm: Mayne Pharma Inc; Status: Terminated; Reported quantity: 1440 cartons; Lot: Lot: 41179A Exp. Jan 2023. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Defective Delivery System: Out of specification for release liner removal force results at the 3-month CRT stability timepoint.
What to do
Voluntary: Firm initiated · Letter
Get an email if CLONIDINE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- CLONIDINE
- Manufacturer
- Mayne Pharma Inc
- Distributor
- Nationwide in the US Market
- Lot
- Lot: 41179A Exp. Jan 2023
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDA70% ISOPROPYL ALCOHOL First aid antiseptic, 4 FL OZ (118 mL) bottle, Made in US with US and foreign componentsJune 29, 2022
- FDATestosterone Cypionate Injection, USP, 200 mg/mL, 1 mL Single-dose vial per carton, Rx only, Distributed by:June 29, 2022
- FDATestosterone Cypionate Injection, USP, 200 mg/mL, 1 mL Single-dose vial per carton, Rx only, Distributed by:June 29, 2022
- FDAAXIUM DETACHABLE COIL SYSTEM REF QC-4-12-HELIX; Axium Detachable Coil System REF QC-10-30-3D;June 22, 2022
- FDAt:slim X2 Insulin Pump with Dexcom G5 Mobile CGM, and t:slim X2 Insulin Pump with Basal-IQ TechnologyJune 22, 2022
- FDAClonidine HCl Injection, 1000 mcg/10 mL (100 mcg/mL),10 mL Single Dose Vial, Rx only, Manufactured for: X-GenJuly 30, 2014
Questions about this recall
Was Clonidine Transdermal System, USP 0.3 mg/day, 4 Patches (NDC 51862-455-01) per Carton (51862-455-04), Rx only, Manufactured for: Mayne Pharma Greenville, NC 27834 recalled?
Yes. FDA published recall D-1152-2022 on June 29, 2022. Reported hazard: Defective Delivery System: Out of specification for release liner removal force results at the 3-month CRT stability timepoint.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: CLONIDINE.